Position in SHC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,209,927
+$379,613 QoQ
Shares Held
180,841
-8.4% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 319 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SHC Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Quantinno Capital Management LP holds $887,159,169 across 28 Diagnostics & Research names. SHC ranks #17 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
670,767 | $117,940,961 | |
| 2 | A |
Agilent Technologies, Inc.
|
870,573 | $115,638,211 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
201,049 | $100,797,926 | |
| 4 | DHR |
Danaher Corp /De/
|
456,740 | $86,999,835 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
164,289 | $86,488,301 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
357,824 | $69,138,753 | |
| 7 | DGX |
Quest Diagnostics Inc
|
252,924 | $53,607,241 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
216,150 | $49,020,658 |
All Filings in SHC
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,209,927 | 180,841 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,830,314 | 197,372 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,728,686 | 1,401,853 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,255,060 | 588,370 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $932,767 | 83,882 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $578,674 | 49,629 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $675,326 | 49,366 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $487,923 | 29,217 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $217,600 | 18,332 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||